Persistence of HBV vaccine's protection and response to hepatitis B booster immunization in 5- to 7-year-old children in the Kohgiloyeh and Boyerahmad Province, Iran

Hepatitis Monthly

Volumn 10, Issue 1, 2010, Pages 17-21

  Yazdanpanah, Behrouz ^a   Safari, Mitra ^a   Yazdanpanah, Shahrzad ^a  

^a YASUJ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Booster dose; Hepatitis B vaccine; Immune protection

Indexed keywords

DNA VACCINE; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; RECOMBINANT DNA; RECOMBINANT HEPATITIS B VACCINE; RECOMBINANT VACCINE;

ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; CHILD; CLINICAL TRIAL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; INFECTION PREVENTION; INFORMED CONSENT; IRAN; MAJOR CLINICAL STUDY; MALE; PARENT; POPULATION RESEARCH; PRESCHOOL CHILD; REVACCINATION; SAMPLING; SCHOOL CHILD;

EID: 77949765808     PISSN: 1735143X     EISSN: 17353408     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. th ed. Cherchil Livingestone; 2005. p. 1864-84.
2. Yu AS, Cheung RC, Keeffe EB. Hepatitis B vaccines. Clin Liver Dis. 2004;8(2):283-300.
3. Malekzadeh R. [Viral hepatitis A, B, C, D, E, G]. Epidemiology and Control of Common Disorders in Iran. 2004:717-9.
4. Ministry of Health and Medical Education, Vice Chancellor of Health and Research. [Health Aspects of Kohgiloyeh and Boierahmad Province]. Tehran: Tabalvor Publications; 2002. p. 61.
5. Pallas Alvarez JR, Gomez Holgado MS, Llorca Diaz J, Delgado Rodriguez M. [Hepatitis B vaccination. Indications of the post-vaccine serologic test and booster doses]. Rev Esp Salud Publica. 2000;74(5-6):475-82.
6. Honorati MC, Palareti A, Dolzani P, Busachi CA, Rizzoli R, Facchini A. A mathematical model predicting anti-hepatitis B virus surface antigen (HBs) decay after vaccination against hepatitis B. Clin Exp Immunol. 1999;116(1):121-6.
7. Seto D, West DJ, Ioli VA. Persistence of antibody and immunologic memory in children immunized with hepatitis B vaccine at birth. Pediatr Infect Dis J. 2002;21(8):793-5.
8. Hassan S, Ziba F. Antibody titer in Iranian children 6 years after hepatitis B vaccine administration. Vaccine. 2007;25(17):3511-4.
9. Behjati M, Mirhoseini N, Ayatollahi J. [A Survey of immune status of primary school age children, 7 years post hepatitis B vaccination]. J Shaheed Sadoughi Univ Med Sci. 2002;10(3):3-7.
10. Mahyar AAF. [Survey of antibody titer against recombinant hepatitis B vaccinations in six-year-old children]. J Guilan Univ Med Sci. 2007;16(61):39-43.
11. Garcia Llop L, Asensi Alcoverro A, Coll Mas P, Ramada Benedito MA, Grafia Juan C. [Anti-HBs titers after a vaccination program in children and adolescents. Should a booster dose be given?]. An Esp Pediatr. 2001;54(1):32-7.
12. Simo Minana J, Gaztambide Ganuza M, Fernandez Millan P, Pena Fernandez M. Hepatitis B vaccine immunoresponsiveness in adolescents: a revaccination proposal after primary vaccination. Vaccine. 1996; 14(2): 103-6.
13. Perera J, Perera B, Gamage S. Seroconversion after hepatitis B vaccination in healthy young adults, and the effect of a booster dose. Ceylon Med J. 2002;47(1):6-8.
14. Hammitt LL, Hennessy TW, Fiore AE, et al. Hepatitis B immunity in children vaccinated with recombinant hepatitis B vaccine beginning at birth: a follow-up study at 15 years. Vaccine. 2007;25(39-40):6958-64.
15. Gold Y, Somech R, Mandel D, Peled Y, Reif S. Decreased immune response to hepatitis B eight years after routine vaccination in Israel. Acta Paediatr. 2003;92(10):1158-62.
16. Li H, Li R, Liao S, Yang J, Zeng X. [Persistence of HB vaccine immune protection and response to hepatitis B booster immunization]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 1998;20(1):54-9.
17. Belloni C, Pistorio A, Tinelli C, et al. Early immunisation with hepatitis B vaccine: a five-year study. Vaccine. 2000;18(14):1307- 11.
18. Liu HB, Meng ZD, Ma JC, et al. A 12-year cohort study on the efficacy of plasma-derived hepatitis B vaccine in rural newborns. World J Gastroenterol. 2000;6(3):381-3.
19. Dentinger C, McMahon B, Dunaway C, et al. Long-term protection from infant hepatitis B virus vaccination among Alaska Natives. In: Infectious Disease Society of America Annual Meeting. Chicago; 2002. p. 177.
20. Boxall EH, J AS, El-Shuhkri N, Kelly DA. Long-term persistence of immunity to hepatitis B after vaccination during infancy in a country where endemicity is low. J Infect Dis. 2004;190(7):1264-9.
21. Petersen KM, Bulkow LR, McMahon BJ, et al. Duration of hepatitis B immunity in low risk children receiving hepatitis B vaccinations from birth. Pediatr Infect Dis J. 2004;23(7):650-5.
22. Dentinger CM, McMahon BJ, Butler JC, et al. Persistence of antibody to hepatitis B and protection from disease among Alaska natives immunized at birth. Pediatr Infect Dis J. 2005;24(9):786-92.
23. Wistrom J, Ahlm C, Lundberg S, Settergren B, Tarnvik A. Booster vaccination with recombinant hepatitis B vaccine four years after priming with one single dose. Vaccine. 1999;17(17):2162-5.
24. Gonzalez ML, Gonzalez JB, Salva F, Lardinois R. A 7-year follow-up of newborns vaccinated against hepatitis B. Vaccine. 1993;11(10): 1033-6.
25. Bucher B, Francioli P, Geudelin B, Fritzell B, Lavanchy D, Frei PC. Immunogenicity of a recombinant Pre-S2-containing hepatitis B vaccine versus plasma-derived vaccine administered as a booster. Eur J Clin Microbiol Infect Dis. 1994;13(3):212-7.
26. Gesemann M, Scheiermann N. Quantification of hepatitis B vaccine-induced antibodies as a predictor of anti-HBs persistence. Vaccine. 1995;13(5):443-7.
27. Krugman S, Davidson M. Hepatitis B vaccine: prospects for duration of immunity. Yale J Biol Med. 1987;60(4):333-9.
28. Lee SD, Lo KJ, Tsai YT, Chan CY, Wu TC. The second booster for the previously hepatitis B vaccine-immunized high-risk children. In: Hollinger FB, Lemon SM, Margolis HS, editors. Viral Hepatitis and Liver Disease. Baltimore: Williams and Wilkins; 1991. p. 776-8.
29. Milne A, Waldon J. Recombinant DNA hepatitis B vaccination in teenagers: effect of a booster at 5 1/2 years. J Infect Dis. 1992;166(4):942.
30. Resti M, Azzari C, Mannelli F, Rossi ME, Lionetti P, Vierucci A. Ten-year follow-up study of neonatal hepatitis B immunization: are booster injections indicated? Vaccine. 1997;15(12-13):1338-40.
31. Trivello R, Chiaramonte M, Ngatchu T, et al. Persistence of anti-HBs antibodies in health care personnel vaccinated with plasma-derived hepatitis B vaccine and response to recombinant DNA HB booster vaccine. Vaccine. 1995;13(2):139-41.
32. West DJ, Watson B, Lichtman J, Hesley TM, Hedberg K. Persistence of immunologic memory for twelve years in children given hepatitis B vaccine in infancy. Pediatr Infect Dis J. 1994;13(8):745-7.
33. Floreani A, Baldo V, Cristofoletti M, et al. Long-term persistence of anti-HBs after vaccination against HBV: an 18 year experience in health care workers. Vaccine. 2004;22(5-6):607-10.
34. Gong J, Li RC, Yang JY, et al. [Long-term efficacy of infant hepatitis B immunization program]. Zhonghua Gan Zang Bing Za Zhi. 2003;11(4):203-5.
35. Xia G, Jia Z, Yan T, et al. [Long-term efficacy and persistence of Chinese infants after receiving only active plasma-derived hepatitis B vaccine]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2002;16(2):146-9.